TRASTUZUMAB IN HER2 POSITIVE EARLY BREAST CANCER: A RETROSPECTIVE AUDIT IN A REGIONAL CANCER CENTER

被引：0
|
作者：
Heng, Sharon [1 ]
Pokharel, Khageshwor [1 ]
Gilbar, Peter [1 ]
Tannock, Margot [1 ]
机构：
[1] Toowoomba Base Hosp, Dept Med Oncol, Toowoomba, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
321
引用
收藏
页码：153 / 153
页数：1
相关论文
共 50 条
  • [21] Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer
    Kaur, Sumanpreet
    Bhattacharyya, Rajasri
    Banerjee, Dibyajyoti
    Shukla, Jaya
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2021, 36 (01) : 124 - 125
  • [22] Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer
    Sumanpreet Kaur
    Rajasri Bhattacharyya
    Dibyajyoti Banerjee
    Jaya Shukla
    Indian Journal of Clinical Biochemistry, 2021, 36 : 124 - 125
  • [23] Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
    Caroline Rönnlund
    Emmanouil G. Sifakis
    Caroline Schagerholm
    Qiao Yang
    Emelie Karlsson
    Xinsong Chen
    Theodoros Foukakis
    Jodi Weidler
    Michael Bates
    Irma Fredriksson
    Stephanie Robertson
    Johan Hartman
    Breast Cancer Research, 26
  • [24] Targeting HER2 in breast cancer: beyond trastuzumab
    EP Winer
    Breast Cancer Research, 13
  • [25] Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
    Ronnlund, Caroline
    Sifakis, Emmanouil G.
    Schagerholm, Caroline
    Yang, Qiao
    Karlsson, Emelie
    Chen, Xinsong
    Foukakis, Theodoros
    Weidler, Jodi
    Bates, Michael
    Fredriksson, Irma
    Robertson, Stephanie
    Hartman, Johan
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [26] Targeting HER2 in breast cancer: beyond trastuzumab
    Winer, F. P.
    BREAST CANCER RESEARCH, 2011, 13
  • [27] Cancer-associated fibroblasts induce trastuzumab resistance in HER2 positive breast cancer cells
    Mao, Yan
    Zhang, Yuzi
    Qu, Qing
    Zhao, Meizhong
    Lou, Ying
    Liu, Junjun
    Huang, Ou
    Chen, Xiaosong
    Wu, Jiayi
    Shen, Kunwei
    MOLECULAR BIOSYSTEMS, 2015, 11 (04) : 1029 - 1040
  • [28] Outcome of HER2 positive breast cancer by PR expression since the introduction of trastuzumab
    Van Asten, K.
    Jongen, L.
    Beuselinck, B.
    Laenen, A.
    Wildiers, H.
    Poppe, A.
    Floriss, G.
    Christiaens, M.
    Neven, P.
    BREAST, 2015, 24 : S119 - S119
  • [29] Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer
    Bulut, Nilufer
    Harputluoglu, Hakan
    Dizdar, Omer
    Altundag, Kadri
    JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (02) : 241 - 241
  • [30] Trastuzumab and vinorelbine combination in the treatment of Her2 positive metastatic breast cancer.
    Bayo, J
    Mayordomo, JI
    Sanchez-Rovira, P
    Perez-Carrion, R
    Illaramendi, J
    Flores, EG
    Bueno, JMG
    Vazquez, MR
    Crespo, C
    Palomo, AG
    Huelva, HJRJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 67S - 67S
12345